Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 125 publications.

Chinthammit C, Mody R, Aguado J, Meyers J. Does weight loss in addition to HbA1c reduction impact health care costs in patients treated with T2D? a retrospective database analysis. Poster presented at the AMCP 2023 Annual Meeting; March 21, 2023. San Antonio, TX.

Parikh RC, DeMartino JK, Krishnarajah G, Hitchens A, Bello F, Meyers J, Levin M. Respiratory syncytial virus–attributable hospitalizations among adults ≥60 years in the United States – a comparison by race/ethnicity. Poster presented at the 2023 Respiratory Synctial Virus Foundation (RSVVW); February 22, 2023. Lisbon, Portugal.

Parikh RC, DeMartino JK, Krishnarajah G, Hitchens A, Bello F, Meyers J, Levin M. Respiratory syncytial virus versus influenza hospitalizations among adults ≥60 years in the United States. Poster presented at the 2023 Respiratory Synctial Virus Foundation (RSVVW); February 22, 2023. Lisbon, Portugal.

Hagino H, Yoshinaga Y, Hamaya E, Lin TC, Ajmera M, Meyers J. A real-world study of treatment patterns among patients with osteoporotic fracture: analysis of a Japanese hospital database. Arch Osteoporosis. 2023 Jan 23;18(1):23. doi: 10.1007/s11657-022-01201-x

Cappellini MD, Yucel A, Meyers J, Jimenez M, Nham T, Glassberg MB, Alashkar F. Clinical burden of β-Thalassemia: findings from a multinational medical record abstraction study. Poster presented at the 64th ASH Annual Meeting and Exposition; December 12, 2022. New Orleans, LA.

Xu X, Chehade M, Kwiatek J, Maslova E, Kielar D, Stirnadel-Farrant H, Meyers J, Aceves S. Demographics and clinical characteristics of patients with eosinophilic esophagitis: a US-based insurance claims data analysis. Poster presented at the 2022 ACAAI Annual Scientific Meeting; November 10, 2022. Louisville, KY.

Poirrier JE, DeMartino JK, Nagar S, Carrico J, Hicks K, Meyers J, Stoddard J. Burden of opioid use for pain management among adult herpes zoster patients in the US and the potential impact of vaccination. Hum Vaccin Immunother. 2022 Nov;18(5):2040328. doi: 10.1080/21645515.2022.2040328

Poirrier JE, Meyers JL, Nagar SP, Patterson BJ, Glasser LI, Jabbour SA. Herpes zoster incidence and burden in adults with type 2 diabetes in the U.S.: a retrospective database analysis. Diabetes Care. 2022 Nov 1;45(11):2585-93. doi: 10.2337/dc21-2053

Mody R, Meyers J, Yu M, Davis K, Levine JA. Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States. Curr Med Res Opin. 2022 Nov;38(11):1785-95. doi: 10.1080/03007995.2022.2085962.

Xu X, Kwiatek J, Chehade M, Aceves S, Maslova E, Kielar D, Stirnadel-Farrant H, Meyers J, Candrilli S, Katial R. Characteristics of and healthcare cost drivers among U.S. patients with eosinophilic esophagitis with high versus non-high all-cause costs: an analysis of insurance claims data. Poster presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting; October 24, 2022. Charlotte, NC.

Xu X, Datto C, Kwiatek J, Meyers J, Candrilli S, Mines D, Stirnadel-Farrant H. Comparison of healthcare resource utilization and costs in patients with and without Bullous Pemphigoid: a retrospective analysis of US health insurance claims data. Poster presented at the ISPOR 2022 Conference; May 18, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).

Ueda K, Takura T, Fujikoshi S, Meyers J, Nagar SP, Enomoto H. Long-term pain management and health care resource use among an employed population in Japan with knee osteoarthritis combined with low back pain. Pain Med. 2021 Dec 11;22(12):3041-50. doi: 10.1093/pm/pnaa424

Meyers J, Hoog M, Mody R, Yu M, Davis K. The health care resource utilization and costs among patients with type 2 diabetes and either cardiovascular disease or cardiovascular risk factors an analysis of a US health insurance database. Clin Ther. 2021 Nov;43(11):1827-42. doi: 10.1016/j.clinthera.2021.09.003

Mody R, Meyers J, Yu M, Levine J, Davis KL. Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the U.S. Poster presented at the 2021 Virtual American Diabetes Association 81st Scientific Session; June 25, 2021.

Bell CF, Meyers J, Ajmera M. Incremental healthcare costs of Eosinophilic Granulomatosis with Polyangiitis (EGPA) compared to asthma: retrospective analysis of commercial claims data in the United States (US). Poster presented at the 2021 Virtual American College of Rheumatology (ACR) Convergence; November 6, 2021. [abstract] Arthritis Rheumatol. 2021; 73(Suppl 10).

Poirrier J-E, Carrico J, DeMartino JK, Hicks KA, Stoddard JJ, Nagar S, Meyers J. The potential for reducing opioid and analgesic prescriptions via herpes zoster vaccination. Poster presented at the IDWeek 2020 Virtual Conference; October 21, 2020.

Ueda K, Takura T, Fujikoshi S, Meyers J, Nagar SP, Enomoto H. Longitudinal assessment of pain management among the employed Japanese population with knee osteoarthritis. Clin Interv Aging. 2020 Jun 26;2020(15):1003-12. doi: 10.2147/CIA.S242083

Poirrier J-E, Nagar S, Meyers J, Glasser L, Jabbour S. Incidence of herpes zoster in patients with type 2 diabetes and consequences for treatment. Poster presented at the 2020 American Diabetes Association 80th Virtual Scientific Sessions; June 13, 2020. Chicago, IL.

Meyers J, Hoog M, Mody R, Yu M, Hasenour C, Davis KL. Burden of cardiovascular disease and cardiovascular (CV) risk in patients with Type 2 diabetes mellitus (T2DM): an analysis of a US health insurance database. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S115. doi: 10.1016/j.jval.2020.04.371

Carreno JJ, Tam IM, Meyers JL, Esterberg E, Candrilli SD, Lodise TP. Corrigendum to: Longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection. Open Forum Infect Dis. 2020 Jan 13;7(1):ofz536. doi: 10.1093/ofid/ofz536

Carreno JJ, Tam IM, Meyers JL, Esterberg E, Candrilli SD, Lodise TP. Longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection. Open Forum Infect Dis. 2019 Nov;6(11):ofz446. doi: 10.1093/ofid/ofz446

Ueda K, Takura T, Fujikoshi S, Meyers J, Nagar SP, Enomoto H. A claims database longitudinal study of the economic burden among patients with knee osteoarthritis in Japan. Poster presented at the 34th Annual Research Meeting of the Japanese Orthopaedic Association; October 17, 2019. Yokohama, Japan.

Meyers JL, Davis KL, Lenz RA, Sakai F, Xue F. Treatment patterns and characteristics of patients with migraine in Japan: a retrospective analysis of health insurance claims data. Cephalalgia. 2019 Oct;39(12):1518-34. doi: 10.1177/0333102419851855

Meyers J, Sinha A, Samant S, Candrilli S. The economic burden of congenital cytomegalovirus disease in the first year of life: a retrospective analysis of health insurance claims data in the United States. Clin Ther. 2019 Jun;41(6):1040-1056. doi: 10.1016/j.clinthera.2019.04.022

Ajmera M, Parikh R, Meyers J. Autoimmune disorders among adults with asthma: an economic outlook. Poster presented at the 2019 ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.

Raccah D, Guerci B, Ajmera M, Davis K, Meyers J, Lew E, Shaunik A, Blonde L. Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: an electronic medical record database analysis. Endocrinol Diabetes Metab. 2019 Mar 28;2(3):e00061. doi: 10.1002/edm2.61

Meyers JL, Candrilli SD, Rausch DA, Yan S, Patterson BJ, Levin MJ. Costs of herpes zoster complications in older adults: a cohort study of US claims database. Vaccine. 2019 Feb 21;37(9):1235-44. doi: 10.1016/j.vaccine.2018.11.079

Blonde L, Brunton SA, Chava P, Zhou R, Meyers J, Davis KL, Dalal MR, Digenio A. Achievement of target A1C <7.0% (<53 mmol/mol) by U.S. type 2 diabetes patients treated with basal insulin in both randomized controlled trials and clinical practice. Diabetes Spectr. 2018 Nov;31(4). doi: 10.2337/ds17-0082

Meyers JL, Candrilli SD, Rausch DA, Yan S, Patterson B, Levin M. Cost of herpes zoster and herpes zoster-related complications among immunocompromised individuals. Vaccine. 2018 Oct 29;36(45):6810-8. doi: 10.1016/j.vaccine.2018.08.080

Nagar SP, Fan Y, Meyers J, Tighe RM. Real-world treatment patterns of nintedanib among patients with idiopathic pulmonary fibrosis in the United States. Poster presented at the 2018 AMCP NEXUS; October 24, 2018. Orlando, FL. [abstract] J Manag Care Pharm. 2018 Oct; 24(10-a):S71.

Sinha A, Meyers J, Samant S, Trantham L, Candrilli S. The incremental burden of congenital cytomegalovirus in the first year of life: a retrospective case-control analysis of Medicaid and commercial claims data. Presented at the 2018 CMV Public Health and Policy Conference; September 25, 2018. Burlington, VT.

Blonde L, Raccah D, Lew E, Meyers J, Nikonova E, Ajmera M, Davis KL, Bertolini M, Guerci B. Treatment intensification in type 2 diabetes: a real world study of 2-OAD regimens, GLP-1 RAx, or basal insulin. Diabetes Ther. 2018 Jun;9(3):1169-84. doi: 10.1007/s13300-018-0429-x

Talbird SE, Hogea CS, Meyers J, Carrico J, Buck PO. Cost-effectiveness of a 10-year revaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (TDaP) vaccine among individuals with pre-existing asthma in the United States. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 23, 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl 1):S153. doi: 10.1016/j.jval.2018.04.1062

Ajmera MR, Meyers J. Economic burden of cardiometabolic disorders among patients with asthma. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 21, 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl 1):S234. doi: 10.1016/j.jval.2018.04.1587

Nagar SP, Rane PP, Fox KM, Meyers J, Davis K, Beaubrun A, Inomata H, Qian Y, Kajinami K. Treatment patterns, statin intolerance, and subsequent cardiovascular events among Japanese patients with high cardiovascular risk initiating statin therapy. Circ J. 2018 Mar 23;82(4):1008-16. doi: 10.1253/circj.CJ-17-0811

Guerci B, Raccah D, Lew E, Meyers J, Shaunik A, Ajmera M, Davis KL, Blonde L. Clinical benefit of simultaneous initiation of basal insulin and GLP-1 in patients with type 2 diabetes and elevated HbA1c as supported by real-world evidence. Poster presented at the EASD 2017 Annual Meeting; September 14, 2017. Lisbon, Portugal.

Rausch D, Levin MJ, Meyers JL, Candrilli SD, Yan S, Krishnarajah G, Patterson B. Cost of herpes zoster and related complications in patients with immunocompromising conditions aged ≥50 years: a US insurance claims data analysis. Presented at the AAFP Family Medicine Experience; September 2017. San Antonio, TX.

Meyers JL, Madhwani S, Rausch D, Candrilli SD, Krishnarajah G, Yan S. Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States. Hum Vaccin Immunother. 2017 Aug 3;13(8):1861-72.

Rausch DA, Levin M, Meyers J, Candrilli S, Yan S, Krishnarajah G, Patterson B. Cost of diagnosed herpes zoster complications in patients age ≥50 years: a US claims data analysis. Poster presented at the IAGG 2017 World Congress; July 23, 2017. San Francisco, CA. [abstract] Innov Aging. 2017 Jul; 1(Suppl 1):902. doi: 10.1093/geroni/igx004.3234

Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017 Jul;145(10):2109-21. doi: 10.1017/S0950268817000887.

Blonde L, Lew E, Raccah D, Meyers J, Ajmera M, Davis K, Bertolini M, Guerci B. Impact of time to basal insulin initiation on glycemic control and health care costs in T2DM patients: an analysis of US commercial claims data. Poster presented at the American Diabetes Association 77th Scientific Sessions; June 10, 2017. San Diego, CA.

Blonde L, Lew E, Raccah D, Meyers J, Ajmera M, Davis K, Bertolini M, Guerci B. A real-world comparison of outcomes in patients receiving three oral antidiabetic therapies, GLP-1, or basal insulin: an analysis of electronic medical record data. Poster presented at the American Diabetes Association 77th Scientific Sessions; June 10, 2017. San Diego, CA.

Bell K, Meyers J, Candrilli SD, Ajmera MR. Characteristics and costs of patients with type 2 diabetes augmenting metformin with dapagliflozin versus glipizide: an analysis of commercial claims data. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A169.

Nagar SP, Fox KM, Rane PP, Beaubrun A, Qian Y, Inomata H, Davis KL, Meyers J, Kajinami K. Incidence of cardiovascular events among secondary prevention patients treated with statins or ezetimibe in Japan. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A261.

Kajinami K, Nagar SP, Meyers J, Rane PP, Davis K, Fox KM, Beaubrun A, Inomata H, Qian Y. Treatment utilization patterns and possible statin intolerance among high-risk patients in a real-world Japanese population. Poster presented at the 81st Annual Scientific Meeting of the Japanese Circulation Society; March 19, 2017. Kanazawa, Japan.

Meyers J, Gajria K, Candrilli SD, Fridman M, Sikirica V. The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. J Comp Eff Res. 2017 Mar;6(2):109-25. doi: 10.2217/cer-2016-0039

Dhamane AD, Ajmera M, Meyers J, Davis KL. Treatment interruption patterns among adalimumab users in a commercially insured managed care population. Poster presented at the 2017 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 2017. Denver, CO. [abstract] J Manag Care Spec Pharm. 2017 Mar; 23(3a):S98.

Raccah D, Lew E, Guerci B, Meyers JL, Ajmera M, Davis KL, Bertolini M, Blonde L. Impact of time to basal insulin initiation on glycaemic control in type 2 diabetes mellitus patients: an electronic medical record database analysis. Poster presented at the 52nd EASD Annual Meeting 2016; September 2016. Munich, Germany.

Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of longitudinal HbA1c and health care costs in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin. Presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 13, 2016. New Orleans, LA.

Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of outcomes in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin: an analysis of electronic medical record data. Poster presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 12, 2016. New Orleans, LA.